A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, transitional cell carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, urothelial carcinoma	Active, not recruiting	Phase 1 / Phase 2	2026-01-07		NCT02989584

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Genentech, Inc.	221
Memorial Sloan Kettering Cancer Center	753

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hartford Healthcare Cancer Institute @ Hartford Hospital	Hartford	United States	7
Lehigh Valley Health Network	Allentown	United States	35
Memorial Sloan Kettering Basking Ridge	Basking Ridge	United States	8
Memorial Sloan Kettering Bergen	Montvale	United States	193
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Memorial Sloan Kettering Commack	Commack	United States	189
Memorial Sloan Kettering Monmouth	Middletown	United States	206
Memorial Sloan Kettering Nassau	Uniondale	United States	193
Memorial Sloan Kettering Westchester	Harrison	United States	204
New York University	New York	United States	12
Ohio State University	Columbus	United States	169